Myrbetriq Alternatives Compared
Myrbetriq | Oxybutynin | VESIcare |
|
---|
Myrbetriq (mirabegron) | Oxybutynin | VESIcare (solifenacin) |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Myrbetriq may be used to relieve symptoms of overactive bladder in adults such as urinary incontinence and urinary frequency. It may also be used to treat the symptoms of neurogenic detrusor... View more |
Prescription and OTC
Oxybutynin helps to relieve symptoms of an overactive bladder and urinary incontinence but it may cause side effects such as a dry mouth and constipation. Prescribed for Urinary Incontinence... View more |
Prescription only
Prescribed for Overactive Bladder, Urinary Incontinence, Urinary Frequency. VESIcare may also be used for purposes not listed in this medication guide. |
Related suggestions Urinary Frequency
Urinary Incontinence
Popular comparisons
|
|||||||||||||||||||||||
More about Myrbetriq (mirabegron) | More about Oxybutynin | More about VESIcare (solifenacin) | ||||||||||||||||||||||||
Generic Status | ||||||||||||||||||||||||||
No lower-cost generic available |
||||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Myrbetriq has an average rating of 4.9 out of 10 from a total of 274 ratings on Drugs.com. 34% of reviewers reported a positive effect, while 48% reported a negative effect. |
Oxybutynin has an average rating of 6.7 out of 10 from a total of 450 ratings on Drugs.com. 55% of reviewers reported a positive effect, while 24% reported a negative effect. |
VESIcare has an average rating of 5.5 out of 10 from a total of 141 ratings on Drugs.com. 39% of reviewers reported a positive effect, while 37% reported a negative effect. |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Side Effects | ||||||||||||||||||||||||||
See also: Myrbetriq side effects in more detail. |
See also: oxybutynin side effects in more detail. |
See also: VESIcare side effects in more detail. |
||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Myrbetriq prices |
View all oxybutynin prices |
View all VESIcare prices and generic prices |
||||||||||||||||||||||||
Dosage Form(s) Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
N/A |
Ditropan XL, Gelnique, Oxytrol, Oxytrol for Women | Other solifenacin brands include: VESIcare LS | ||||||||||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
50 hours |
2.3 hours |
68 hours |
||||||||||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 231 drugs are known to interact with Myrbetriq:
|
A total of 276 drugs are known to interact with oxybutynin:
|
A total of 480 drugs are known to interact with VESIcare:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
June 28, 2012 |
July 16, 1975 |
November 19, 2004 |
||||||||||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient resources | ||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.